A new cancer gene has been discovered by a research group at the Sahlgrenska Academy.
The gene causes an insidious form of glandular cancer usually in the head and neck and in women also in the breast. The discovery could lead to quicker and better diagnosis and more effective treatment, according to the study which is published in the prestigious scientific journal Proceedings of the National Academy of Sciences (PNAS).
Mothers Happy to Let Children Know Their Cancer Genetic Test Results
A new study has revealed the extreme satisfaction on the part of mothers who decide to let children know about their cancer genetic test results as compared to those who decide to keep it a secret.
Advertisement
The cancer caused by this new cancer gene is called adenoid cystic carcinoma and is a slow-growing but deadly form of cancer. The research group can now show that the gene is found in 100 percent of these tumors, which means that a genetic test can easily be used to make a correct diagnosis.
"Now that we know what the cancer is down to, we can also develop new and more effective treatments for this often highly malignant and insidious form of cancer," says professor Göran Stenman, who heads the research group at the Lundberg Laboratory for Cancer Research at the Sahlgrenska Academy.
![Study Pinpoints Novel Cancer Gene and Biomarker]( "Study Pinpoints Novel Cancer Gene and Biomarker")
Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene - the first in its family to be linked to cancer - demonstrates how the panoramic view of genomics.
"One possibility might be to develop a drug that quite simply turns off this gene," the expert added.
The newly discovered cancer gene is what is known as a fusion gene, created when two healthy genes join together as a result of a chromosome change.
"Previously it was thought that fusion genes pretty much only caused leukemia, but our group can now show that this type of cancer gene is also common in glandular cancer," says Stenman.
One of the two genes that form the fusion gene is known as MYB. Among other things, this gene controls cell growth and makes sure that the body gets rid of cells that are no longer needed. It has long been known to be a highly potent cancer gene in animals, but for a long time there was no evidence of the gene being involved in the development of tumors in humans.
"We suggested back in 1986 that the MYB gene might be involved in this form of cancer, but it's only recently that we've had access to the tools needed to prove it," says Stenman.
The research group has also looked at the mechanism behind the transformation of the normal MYB gene into a cancer gene. Genes can be compared to blueprints for proteins. Carefully controlled regulating systems then determine when and how much of each protein is formed. One such regulating system, discovered recently, is microRNA, which can turn genes on and off. When this cancer gene forms, this important control system is put out of action, leading to activation of the gene and massive overproduction of an abnormal MYB protein with carcinogenic properties.
Source: ANI
ARU
Study Pinpoints Novel Cancer Gene and Biomarker
Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene - the first in its family to be linked to cancer - demonstrates how the panoramic view of genomics.
Advertisement
"One possibility might be to develop a drug that quite simply turns off this gene," the expert added.
The newly discovered cancer gene is what is known as a fusion gene, created when two healthy genes join together as a result of a chromosome change.
"Previously it was thought that fusion genes pretty much only caused leukemia, but our group can now show that this type of cancer gene is also common in glandular cancer," says Stenman.
One of the two genes that form the fusion gene is known as MYB. Among other things, this gene controls cell growth and makes sure that the body gets rid of cells that are no longer needed. It has long been known to be a highly potent cancer gene in animals, but for a long time there was no evidence of the gene being involved in the development of tumors in humans.
"We suggested back in 1986 that the MYB gene might be involved in this form of cancer, but it's only recently that we've had access to the tools needed to prove it," says Stenman.
The research group has also looked at the mechanism behind the transformation of the normal MYB gene into a cancer gene. Genes can be compared to blueprints for proteins. Carefully controlled regulating systems then determine when and how much of each protein is formed. One such regulating system, discovered recently, is microRNA, which can turn genes on and off. When this cancer gene forms, this important control system is put out of action, leading to activation of the gene and massive overproduction of an abnormal MYB protein with carcinogenic properties.
Source: ANI
ARU
Discovery of Anti-Cancer Gene Holds Promise For Therapy
Starting with the tiny fruit fly, and then moving into mouse and human patients, researchers at VIB connected to the Center for Human Genetics (K.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable